Early effects of mood stabilizers on the Akt/GSK-3β signaling pathway and on cell survival and proliferation

Psychopharmacology

Volumn 205, Issue 3, 2009, Pages 419-429

  Aubry, Jean Michel ^a   Schwald, Michèle ^a   Ballmann, Eladia ^a   Karege, Félicien ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Akt GSK 3 ; Mood stabilizers; Neuroprotection; SH SY5Y cell proliferation; Signaling axis

Indexed keywords

CARBAMAZEPINE; CLOZAPINE; GLYCOGEN SYNTHASE KINASE 3BETA; HALOPERIDOL; LAMOTRIGINE; LITHIUM CHLORIDE; MOOD STABILIZER; OLANZAPINE; PROTEIN KINASE B; VALPROIC ACID;

ARTICLE; CELL PROLIFERATION; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; DRUG MECHANISM; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ANTICONVULSANTS; CELL DEATH; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; GLYCOGEN SYNTHASE KINASE 3; HUMANS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; PSYCHOTROPIC DRUGS; SIGNAL TRANSDUCTION;

EID: 67651005342     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-009-1551-2     Document Type: Article

References (57)

1. Aubry JM, Ferrero F, Schaad N (2007) Pharmachotherapy of bipolar disorders. J Wiley (ed.), Chester
2. JM Beaulieu RR Gainetdinov MG Caron 2009 Akt/GSK3 signaling in the action of psychotropic drugs Annu Rev Pharmacol Toxicol 49 327 347
3. CL Bowden AM Brugger AC Swann JR Calabresse PG Janicak 1994 Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study group J Am Med Association 271 918 924
4. CL Bowden 1996 Dosing strategies and time course of response to antimanic drugs J Clin Psychiatry 57 Suppl 13 4 9
5. P Brambilla F Barale JC Soares 2003 Atypical antipsychotics and mood stabilization in bipolar disorder Psychopharmacology 166 315 332
6. Brunet A, Datta SR, Greenberg M (2001) Transcription-dependent and -independent control of neuronal survival by the PI3K-Akt signaling pathway. Curr Opin Neurobiol 11:297-305
7. JR Calabrese RF Huffman RL White S Edwards 2008 Lamotrigine in the acute treatment of bipolar depression: results of five double-blind, placebo-controlled clinical trials Bipolar Disord 2008 10 323 333
8. G Chen KA Hasanat JM Bebchuk GJ Moore D Glitz HK Manji 1999 Regulation of signal transduction pathways and gene expression by mood stabilizers and antidepressants Psychosomatic Med 61 599 617 (Pubitemid 29455084)
9. DM Chuang 2005 The Antiapoptotic Actions of Mood Stabilizers: Molecular Mechanisms and Therapeutic Potentials Annals of New York Academy of Science 1053 195 204
10. Ciapparelli A, Dell'Osso L, Pini S, Chiavacci MC, Fenzi M, Cassano GB (2000) Clozapine for treatment-refractory schizophrenia, schizoaffective disorder, and psychotic bipolar disorder: a 24-month naturalistic study. J Clin Psychiatry 61:329-334
11. A Ciapperelli L Dell'Osso A Bandettini di Poggio C Carmassi D Cecconi GB Cassano 2003 Clozapine in treatment-resistant patients with schizophrenia, schizoaffective disorder or psychotic bipolar disorder: a naturalistic 48-month follow-up study J Clin Psychiatry 64 451 458
12. Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA (1995). Inhibition of glycogen synthase kinase-3 by insulin-mediated Protein kinase B. Nature 378:785-789
13. P De Sarno X Li RS Jope 2002 Regulation of Akt and glycogen synthase kinase-3β phosphorylation by sodium valproate and lithium Neurpharmacology 43 1158 1164
14. E Di Daniel AW Mudge PR Maycox 2005 Comparative analysis of the effects of four mood stabilizers in SH-SY5Y cells and in primary neurons Bipolar Disorder 7 33 41
15. DS Dwyer X-H Lu AM Freeman 2003 Neuronal glucose metabolism and schizophrenia: therapeutic prospects? Expert Rev Neurotherapeutics 3 29 40
16. AJ Gelenberg HS Hopkins 1996 Antipsychotics in bipolar disorder J Clin Psychiatry 57 Suppl 9 49 52
17. TD Gould JA Quiroz J Sing CA Zarate HK Manji 2004 Emerging experimental therapeutics for bipolar disorder; insights from the molecular and cellular actions of current mood stabilzers Mol Psychiatry 9 734 755
18. RS Grimes CA Jope 2001 The multifaceted roles of glycogen synthase kinase 3β in cellular signalling Progr Neurobiology 65 391 426
19. N Gurvich PS Klein 2002 Lithium and Valproic acid: parallels and contrasts in diverse signaling contexts Pharmacol Ther 96 45 66
20. E Hajduch GJ Litherland HS Hundal 2001 Protein kinase B (PKB/Akt)-a key regulator of glucose transport? FEBS Lett 492 199 203 (Pubitemid 32217828)
21. AJ Harwood G Agam 2003 Search for common mechanism for mood stabilizers as plasticity enhancers in the treatment of neuropsychiatric disorders J Clin Psychiatry 64 Suppl 5 179 189
22. P Heiser F Enning J-C Krieg H Vedder 2007 Effects of haloperidol, clozapine and olanzapine on the survival of human neuronal and immune cells in vitro J Psychopharmacol 21 851 856
23. SC Hsiung M Adlersberg V Arango JJ Mann H Tamir KP Liu 2003 Attenuated 5-HT1A receptor signaling in brains of suicide victims: involvement of adenylyl cyclase, phosphatidylinositol 3-kinase, Akt and mitogen-activated protein kinase J Neurochem 87 162 194
24. RS Jope MB Williams 1994 Lithium and brain signal transduction systems Bioch Pharmacology 47 429 441
25. RS Jope GVW Johnson 2004 The glamour and gloom of glycogen synthase kinase-3 Trends Biochem Sci 29 95 102
26. RS Jope GN Bijur 2002 Mood stabilizers, glycogen synthase kinase-3beta and cell survival Mol Psychiatry 7 Suppl 1 S35 S45
27. PJ Kahle JW Maas 1997 Use of CellTiter 96 reagents in semi automatic assay of neuronal survival Neural Notes 3 12 14
28. UG Kang MS Seo MS Roh Y Kim SC Yoon YS Kim 2004 The effects of clozapine on the GSK-3-mediated signaling pathway FEBS Lett 560 11 119
29. F Karege N Perroud S Burkhardt M Schwald E Ballmann R La Harpe A Malafosse 2007 Alteration in Kinase activity but not in protein levels of kinase B and glycogen synthase kinase-3β in ventral prefrontal cortex of depressed suicide victims Biol Psychiatry 61 240 245
30. NR Kim SW Park JG Lee YH Kim 2008 Protective effects of olanzapine and haloperidol on serum withdrawal-induced apoptosis in SH-SY5Y cells Prog Neuro-Psychopharmacol Biol Psychiatry 32 633 642
31. PS Klein DA Melton 1996 A molecular mechanism for the effect of lithium on development PNAS USA 93 8455 8459
32. J Kornhuber A Schulz J Wiltfang 1999 Persistance of haloperidol in human brain tissue Am J Psychiatry 156 885 890
33. N Kozlovsky S Amar TH Belmaker G Agam 2006 Psychoptropic drugs affect ser9-phosphorylated GSK-3β protein levels in rident frontal cortex Int J Neuropsychopharmacol 9 337 342
34. M Lawlor D Alessi 2001 PKB/Akt: a key mediator of cell proliferation, survival and insulin responses? J Cell Science 114 2903 2910
35. M Lesort A Greendorfer C Stockmeier GV Johnson RS Jope 1999 Glycogen synthase kinase-3beta, beta-catenin, and tau in postmortem bipolar brain J Neural Transm 106 1217 1222
36. R Li RS El-Mallahk 2000 A novel evidence of different mechanisms of lithium and valproate neuroprotective action on human SY5Y neuroblatoma cells: caspase-3 dependency Neurosci Lett 294 147 150
37. X Li GN Bijur RS Jope 2002 Glycogen synthase kinase-3beta, mood stabilizers, and neuroprotection Bipolar Disorder 4 137 144
38. Li X, Zhu W, Roh MS, Friedman AB, Rosborough K, Jope RS (2004) In vivo regulation of glycogen synthase kinase-3beta (GSK3beta) by serotonergic activity in mouse brain. Neuropsychopharmacology 29:1426-31
39. KJ Livak TD Schmittgen 2001 Analysis of relative gene expression data using real-time quantitative PCR and the 2(delta-delta) Ct method Methods 25 4 412 408
40. X-H Lu RJ Bradley DS Dwyer 2004 Olanzapine produces trophic effects in vitro and stimulates phopshotylation of Akt/PKB, ERK1/2 and the mitogen-activated protein kinase p38 Brain Research 1011 58 68
41. HK Manji GJ Moora G Chen 1999 Lithium at 50: have the neuroprotective effects of this unique cation been overlooked? Biol Psychiatry 46 949 940
42. HK Manji RS Duman 2001 Impairments of neuroplasticity and cellular resilience in severe mood disorders: implications for the development of novel therapeutics Psychopharmacol Bull 35 5 49
43. GJ Moore JM Bebchuk IB Wids G Chen HK Manji 2000 Lithium-induced increase in human brain grey matter Lancet 356 1241 1242
44. OV Olesen K Linnet 1999 Olanzapine serum concentration in psychiatric patients given standard doses: the influence of comediacation Ther Drug Monit 21 87 90
45. GN Pandey Y Dwivedi HS Rizavi 2009 GSK-3β gene expression in human postmortem brain: regional distribution, effects of age and suicide Neurochem Res 34 274 285
46. PJ Perry KA Bever S Arndt MD Combs 1998 Relationship between patient variables and plasma clozapine concentrations: a dosing nomogram Biol Psychiatry 44 733 738
47. MD Robertson MM [tmp] McMullin 2000 Olanzapine concentrations in clinical serum and postmortem blood specimens-when does therapeutic become toxic? J Forensic Sci 45 418 421
48. M-S Roh MS Seo Y Kim 2007 Haloperidol and clozapine differently regulate signals upstream of glycogen synthase kinase-3 in the rat frontal cortex Exp Mol Med 39 353 360
49. YI Sheline 2003 Neuroimaging studies of mood disorder effects on the brain Biol Psychiatry 54 338 352
50. SY Shin BH Choi J Ko SH Kim YS Kim YH Lee 2006 Clozapine, a neuroleptic agent, inhibits Akt by counteracting Ca∈±∈2/calmodulin in PTEN-negative U-87MG human glioblastoma cells Cell Signalling 18 1876 1886
51. C Simhandl E Denk K Thau 1993 The comparative efficacy of carbamazepine low and high serum level and lithium carbonate in the prophylaxis of affective disorders J Affect Disord 28 4 221 231
52. V Stambolic L Ruel JR Woodgett 1996 Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signaling in intact cells Curr Biol. 6 1664 1668
53. SJ Tsai YJ Liou CJ Hong YW Yu TJ Chen 2008 Glycogen synthase kinase-3β gene is associated with antidepressant treatment response in Chinese major depressive disorder Pharmacogenomics J 8 384 390
54. X Xie RM Hagan 1998 Cellular and molecular actions of lamotrigine: possible mechanisms of efficacy in bipolar disorder Neuropsychobiology 38 119 130
55. LN Yatham JM Goldstein E Vieta 2005 Atypical antipsychotics in Bipolar depression: potential mechanisms of action J Clin Psychiatry 66 40 48
56. LN Yatham SH Kennedy C O'Donovan SV Parikh G [tmp] MacQueen RS [tmp] McIntyre V Sharma S Beaulieu 2006 Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007 Bipolar Disorder 8 721 739
57. Zeng X, Tamai K, Doble B, Li S, Huang H, Habas R, Okamura H, Woodgett J, He X (2005) A dual-kinase mechanism for Wnt co-receptor phosphorylation and activation. Nature 438:873-877